Posted inStock
Pfizer (PFE) Stock Falls to $26.62 After Downgrade Despite FDA Priority Review Boost
Pfizer (NYSE: PFE) shares fell sharply in midday trading, sliding to $26.62, down $0.75 or 2.74%. The move left the stock lagging the broader healthcare group, which was down 0.85%,…







